Seth Berkley

So there were lots of logistics problems like that.

The Pfizer vaccine used a non-standard syringe size.

So we had to find people to produce vaccines.

you know, tens of millions, hundreds of millions of those size of auto-disabled syringes because we didn't want people to get infected.

So it really is a story of, you know, money, political will, logistics, and all of that.

The India story, I'm not going to go into detail, but, you know, it was very hard because what happened was India, because they had doses and WHO hadn't pre-qualified, started giving them to countries around and, you know,

People love that.

It was vaccine diplomacy.

And, you know, the president, you know, was getting attention.

And then lo and behold, when the when the Delta epidemic hit India, we saw those horrible pictures of funeral pyres burning everywhere.

You know, the opposition said, well, look, here's the here's the prime minister giving out, you know, vaccines to all these people that were Indian vaccines.

And and they never stopped.

the export officially, but all of a sudden there was no export at all.

And that, as you said, led us to be about closer to 600 million doses short.

And that's one of the reasons there were such terrible delays.

But one statistic, just to finish before we go back to the next question, is at the end, 57% of people

In the poorest, 92 countries received a primary dose.

That compared to about 67% globally.

So it wasn't quite equitable, but also there is more high-risk populations in places that have more elderly populations, et cetera.

So we don't know what that number exactly should be, but it was very delayed, which is the problem.